Skip to main content
logo
Alaunos Therapeutics, Inc. (TCRT)
NASDAQ: TCRT · Real-Time Price · USD
2.610
+0.080 (3.16%)
May 5, 2026, 4:00 PM EDT - Market closed

Alaunos Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
68317156236
Market Cap Growth
55.18%148.13%-82.00%-89.11%-33.76%-56.44%
Enterprise Value
4.876.21.9710.93119.19180.29
Last Close Price
2.613.231.9110.6197.37163.50
PE Ratio
--1.47-0.65-0.48-3.73-2.95
PS Ratio
1250.961517.76305.843397.8653.41591.91
PB Ratio
2.763.521.482.694.054.06
P/TBV Ratio
2.362.921.482.693.664.03
P/FCF Ratio
--2.56-0.62-0.56-5.30-3.64
P/OCF Ratio
--2.65-0.62-0.56-5.34-3.83
EV/Sales Ratio
973.961240.76196.742185.4640.79453.00
EV/EBITDA Ratio
--1.47-0.41-0.34-3.68-2.41
EV/EBIT Ratio
--1.47-0.41-0.32-3.40-2.32
EV/FCF Ratio
--2.09-0.40-0.36-4.05-2.78
Debt / Equity Ratio
-0000.060.36
Debt / EBITDA Ratio
-----0.60-0.39
Debt / FCF Ratio
-----0.66-0.45
Net Debt / Equity Ratio
-0.64-0.64-0.53-0.96-0.51-0.80
Net Debt / EBITDA Ratio
0.330.330.230.190.600.62
Net Debt / FCF Ratio
0.460.470.220.200.660.72
Asset Turnover
0.000.000.000.000.040.00
Quick Ratio
1.711.711.583.101.624.74
Current Ratio
2.452.453.984.222.234.91
Return on Equity (ROE)
-198.10%-198.10%-111.80%-156.66%-78.11%-86.52%
Return on Assets (ROA)
-147.70%-147.70%-87.35%-93.63%-43.94%-64.30%
Return on Invested Capital (ROIC)
-485.63%-485.63%-790.80%-355.45%-230.93%-618.07%
Return on Capital Employed (ROCE)
-200.43%-200.43%-114.98%-145.58%-58.71%-75.00%
Earnings Yield
-68.46%-68.11%-152.88%-207.07%-26.80%-33.95%
FCF Yield
-47.44%-39.10%-162.54%-178.58%-18.87%-27.50%
Buyback Yield / Dilution
-21.68%-21.68%-0.11%-10.50%-1.27%-2.27%
Total Shareholder Return
-21.68%-21.68%-0.11%-10.50%-1.27%-2.27%
Updated Mar 31, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q